1 terminated, 1 unknown. 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 4 | 1 | Unknown 1 |
Follow ethyl pyruvate: new trials by email Literature Review of ethyl pyruvate trials Research Report on ethyl pyruvate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 17% Salicylate Versus 17% Salicylate-Ethyl Pyruvate for Plantar Foot Warts 17% Salicylate with ethyl pyruvate, Salicylates - Warts | Phase 4 | Unknown | Grossman, Michael, D.P.M. | 100 | 2011-11-01 | 2012-10-23 |
| CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB) CTI-01 (ethyl pyruvate) - Coronary Disease, Heart Valve Diseases | Phase 2 | Terminated | Critical Therapeutics | 150 | 2005-04-01 | 2006-03-17 |
Coronary Disease (1) · Endotoxemia (1) · Heart Valve Diseases (1) · Inflammation (1) · Warts (1)
Critical Therapeutics (1) · Grossman, Michael, D.P.M. (1)
United States (2)
Michael R Grossman, DPM (1) · Walter Newman, Ph.D. (1)